Literature DB >> 4124808

Treatment of erythema nodosum leprosum with thalidomide.

L Levy, P Fasal, N E Levan, R I Freedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4124808     DOI: 10.1016/s0140-6736(73)90829-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.

Authors:  Brenda De Keersmaecker; Sabine D Allard; Patrick Lacor; Rik Schots; Kris Thielemans; Joeri L Aerts
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

2.  Use of thalidomide in leprosy.

Authors:  C L Crawford
Journal:  BMJ       Date:  1991-10-26

3.  Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.

Authors:  Kristoffer E Leon; Jorge L Salinas; Robert W McDonald; Anandi N Sheth; Jessica K Fairley
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

4.  Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.

Authors:  Yuki Hirose; Tomohiro Kitazono; Maiko Sezaki; Manabu Abe; Kenji Sakimura; Hiromasa Funato; Hiroshi Handa; Kaspar E Vogt; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-26       Impact factor: 11.205

5.  Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.

Authors:  Brahmaiah Upputuri; Michael Sukumar Pallapati; Patrick Tarwater; Aparna Srikantam
Journal:  PLoS Negl Trop Dis       Date:  2020-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.